These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


170 related items for PubMed ID: 2662234

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A placebo-controlled comparison of the effect of nortriptyline and phenelzine on orthostatic hypotension in elderly depressed patients.
    Georgotas A, McCue RE, Friedman E, Cooper TB.
    J Clin Psychopharmacol; 1987 Dec; 7(6):413-6. PubMed ID: 3323263
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. 10-Hydroxynortriptyline and treatment effects in elderly depressed patients.
    McCue RE, Georgotas A, Suckow RF, Cooper TB.
    J Neuropsychiatry Clin Neurosci; 1989 Dec; 1(2):176-80. PubMed ID: 2521060
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of platelet monoamine oxidase in depressed subjects treated with phenelzine.
    Davidson J, McLeod MN, White HL.
    Am J Psychiatry; 1978 Apr; 135(4):470-2. PubMed ID: 345826
    [Abstract] [Full Text] [Related]

  • 8. Response of depressive symptoms to nortriptyline, phenelzine and placebo.
    Georgotas A, McCue RE, Friedman E, Cooper TB.
    Br J Psychiatry; 1987 Jul; 151():102-6. PubMed ID: 3676606
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tyramine sulfate excretion may be a better predictor of antidepressant response than monoamine oxidase activity.
    Stewart JW, Harrison W, Cooper TB, Quitkin FM.
    Psychiatry Res; 1988 Aug; 25(2):195-201. PubMed ID: 3051071
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline and placebo.
    Raft D, Davidson J, Wasik J, Mattox A.
    Neuropsychobiology; 1981 Aug; 7(3):122-6. PubMed ID: 7231652
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly.
    Georgotas A, McCue RE, Hapworth W, Friedman E, Kim OM, Welkowitz J, Chang I, Cooper TB.
    Biol Psychiatry; 1986 Oct; 21(12):1155-66. PubMed ID: 3756264
    [Abstract] [Full Text] [Related]

  • 15. Electrocardiographic effects of nortriptyline, phenelzine, and placebo under optimal treatment conditions.
    Georgotas A, McCue RE, Friedman E, Cooper TB.
    Am J Psychiatry; 1987 Jun; 144(6):798-801. PubMed ID: 3592003
    [Abstract] [Full Text] [Related]

  • 16. Phenelzine v imipramine in atypical depression. A preliminary report.
    Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison W, Rabkin J, Tricamo E, Markowitz JS, Klein DF.
    Arch Gen Psychiatry; 1984 Jul; 41(7):669-77. PubMed ID: 6375621
    [Abstract] [Full Text] [Related]

  • 17. Relapse of depressed patients after effective continuation therapy.
    Georgotas A, McCue RE.
    J Affect Disord; 1989 Jul; 17(2):159-64. PubMed ID: 2527891
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Acetylation phenotype, platelet monoamine oxidase inhibition, and the effectiveness of phenelzine in depression.
    Davidson J, McLeod MN, Blum MR.
    Am J Psychiatry; 1978 Apr; 135(4):467-9. PubMed ID: 345825
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.